Mayo Clinic Rochester

Overview

The blood and marrow transplant program at Mayo Clinic Rochester was established in 1982. We've performed more than 10,000 blood and marrow transplants. Our integrated group practice and combined inpatient/outpatient hospital unit optimize coordinated care for patients. We perform myeloablative and non-myeloablative unrelated donor transplants, including cord blood and haploidentical transplants.

This center has been performing allogeneic transplants since 1982 and has been an NMDP transplant center since August 1995.

Attending physicians

Adult - Hassan Alkhateeb, Stephen Ansell, Moritz Binder, Francis Buadi, David Dingli, Angela Dispenzieri, Urshila Durani, Morie A. Gertz, Wilson I. Gonsalves, Shahrukh Hashmi, Suzanne Hayman, William Hogan, Patrick Johnston, Cook Joselle, Prashant Kapoor, Saad Kenderian, Taxiarchis Kourelis, Shaji Kumar, Abishek Mangaonkar, Aasiya Matin, Hefazi Torghabeh Mehrdad, Ivana Micallef, Eli Muchtar, Jonas Paludo, Mrinal Patnaik, Luis Porrata, Mithun V. Shah, Jose Villasboas Bisneto, Rahma Warsame
Pediatric - Asmaa Ferdjallah, Mira Kohorst

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants

Adult and pediatric

Other programs and services

The Gift of Life Transplant House provides transplant patients and their caregivers with high quality, affordable accommodations in a supportive, home-like environment. http://gift-of-life.org/ The Ronald McDonald House of Rochester, Minnesota provides a "home away from home" for families with seriously ill children seeking medical care in Rochester. http://rmhmn.org/ The Rochester Convention & Visitor Bureau has many lodging options available to patients and visitors. https://www.experiencerochestermn.com/The Stephen and Barbara Slaggie Family Cancer Education Center is open to cancer patients, family and friends. https://www.mayoclinic.org/patient-visitor-guide/education-centers/cancer-education.

Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 322 patients.

The actual 1-year survival of these patients is 78.1%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 72.8% and 81.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.

The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.

Total adult transplants

773

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 7	PBSC 67	Cord blood 0	Total 74
Unrelated donor	Marrow 9	PBSC 134	Cord blood 0	Total 143
Total allogeneic	Marrow 16	PBSC 201	Cord blood 0	Total 217
Autologous	Marrow Both marrow & PBSC 556	PBSC —	Cord blood —	Total 556
Total combined	Marrow Both marrow & PBSC 773	PBSC —	Cord blood 0	Total 773

Total pediatric transplants

31

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 8	PBSC 2	Cord blood 0	Total 10
Unrelated donor	Marrow 7	PBSC 2	Cord blood 0	Total 9
Total allogeneic	Marrow 15	PBSC 4	Cord blood 0	Total 19
Autologous	Marrow Both marrow & PBSC 12	PBSC —	Cord blood —	Total 12
Total combined	Marrow Both marrow & PBSC 31	PBSC —	Cord blood 0	Total 31

All Diseases

Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)

	0-18	19-44	45-64	65+	Total
Related	0-18 10	19-44 22	45-64 32	65+ 20	Total 84
Unrelated	0-18 11	19-44 28	45-64 49	65+ 64	Total 152
Autologous	0-18 13	19-44 76	45-64 255	65+ 224	Total 568
Total	0-18 34	19-44 126	45-64 336	65+ 308	Total 804

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants can be found:

U.S. Transplant Data by Center (Opens in a new tab)
report at blood cell.transplant.hrsa.gov
List of diseases

Transplant center resources

Transplant center coordinator

Lindsay Herr

Phone: (507) 422-5332

Email: herr.lindsay@mayo.edu

Financial representative

Transplant Financial Services

Phone: (507) 538-5429

Email: entertranprauthtm@mayo.edu

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

More resources

Choosing a transplant center
Preparing for transplant
Learn about transplant outcomes and treatment decisions (Opens in a new tab)
Support and resources (including non-English materials)
U.S. Transplant Data by Center (Opens in a new tab)
at blood cell.transplant.hrsa.gov

This center has separate survivorship programs for adult and pediatric patients.

Please select the program you are interested in.